Riyadh, Saudi Arabia

Manal Fawzy Elkhadragy


Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 61(Granted Patents)


Location History:

  • Hewan, EG (2019)
  • Cairo, EG (2019 - 2020)
  • Riyadh, SA (2017 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Manal Fawzy Elkhadragy: Innovator in Bee Venom Nanoparticles

Introduction

Manal Fawzy Elkhadragy is a prominent inventor based in Riyadh, Saudi Arabia. She has made significant contributions to the field of nanotechnology, particularly through her innovative work with bee venom nanoparticles. With a total of 10 patents to her name, her research has the potential to impact pharmaceutical applications significantly.

Latest Patents

Among her latest patents, Manal has developed methods for synthesizing bee venom nanoparticles. These nanoparticles are created by drying bee venom and suspending it in a solvent to form a solution. The process involves spraying this solution into boiling water under ultrasonic conditions, which results in the formation of bee venom nanoparticles. The final product is then stirred and freeze-dried. These nanoparticles are noted for their antimicrobial activities and can be utilized in various pharmaceutical compositions.

Career Highlights

Manal Fawzy Elkhadragy is affiliated with King Saud University, where she conducts her research and development. Her work has garnered attention for its innovative approach to utilizing natural substances in nanotechnology.

Collaborations

Manal collaborates with notable colleagues, including Hany Mohamed Yehia and Manal Ahmed Gasmelseed Awad. Their combined expertise enhances the research and development efforts in their field.

Conclusion

Manal Fawzy Elkhadragy's contributions to the field of nanotechnology, particularly through her work on bee venom nanoparticles, highlight her role as an influential inventor. Her innovative methods and dedication to research continue to pave the way for advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…